Review on anti-alzheimer drug development: approaches, challenges and perspectives-Reference-Cited by-同舟云学术

Review on anti-alzheimer drug development: approaches, challenges and perspectives

Published:2024 Issue:16 Volume:14 Page:11057-11088
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Abdallah Abdallah E.¹^ORCID

Affiliation:

1. Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, 11884, Cairo, Egypt

Abstract

Alzheimer has many crucial factors that should be considered in order to get better results from clinical trials. Benzimidazole and its isosteres represent significant scaffolds for designing potential multi-target anti-alzheimer molecules.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D3RA08333K

Reference274 articles.

1. Alzheimer's Disease is Incurable but Preventable

2. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics

3. Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment

4. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

5. Alzheimer’s disease: Causes & treatment – A review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Delivery Systems with Prebiotic and Neuroprotective Potential of Industrial-Grade Cannabis sativa L.;Molecules;2024-07-29

2. Exploring the therapeutic potential of dioscin and diosgenin in neurological disorders;Brain Behavior and Immunity Integrative;2024-07